Prescriptions for antiparasitic drug ivermectin surged amid pandemic, analysis shows
The average number of monthly prescriptions for the antiparasitic drug ivermectin surged amid the infectious-disease pandemic, according to a claims analysis which suggested a sharp increase in off-label use. The drug isn’t authorized or approved by the FDA to prevent or treat COVID-19, however ivermectin misuse and overdoses climbed amid the pandemic, as indicated by…